eWeLL Co.,Ltd.

5038.T
Health Information Services
2026/08/21 Updated
Market Cap: $213.0M (¥33.9B)
Stock Price: $14.08 (¥2,238)
Exchange Rate: 1 USD = ¥158.98

Q1 FY2026 Earnings Explanation Meeting Q&A (Summary)

The target of 200 visits and routes via AI in July is expected to be achieved with high confidence. Revenue increased by 26.5% in the first quarter, surpassing plans. Capital policies and competitive advantages are also explained.

Importance:
Page Updated: May 25, 2026
IR Disclosure Date: May 25, 2026

Key Figures

  • Sales: Unknown (up 26.5% in Q1)
  • Growth Rate: Expected to exceed the average of 21.9% in the medium-term plan
  • Recruitment Plan: Proceeding as planned mainly in customer support departments

AI要約

Financial Performance Overview

Revenue for the first quarter of this fiscal year increased by 26.5% YoY, exceeding the plan. Regarding the AI visit schedule and route targets, 500 actual uses and familiarity with operations have already been achieved, with explanations provided for the basis of reaching 200 and potential upside. Sales are progressing well and are expected to outpace the midpoint plan’s average growth rate of 21.9%.

Future Outlook and Strategies

The company continues to plan for an average growth rate exceeding the midpoint of its medium-term management plan, with recruitment in sales, development, and BPaaS departments proceeding as scheduled. Capital policy prioritizes growth investments, with ongoing consideration of M&A and treasury stock acquisitions. Competitive advantages are maintained through data and service integration accumulated over 12 years, with half of the cancellations attributed to client-side factors and measures being taken to reduce cancellations.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

eWeLL

Company overview · Stock price · Financial data · All IR

View company page →